Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Stroke. 2011 Sep 1;42(11):3183–3189. doi: 10.1161/STROKEAHA.111.623462

Table 3.

Cerebrovascular Disease Pathology and Parkinsonism*

Pathology Measure *Global Parkinsonian β (SE, p value) * Parkinsonian Gait β (SE, p value) Rigidity β (SE,p value) Bradykinesia β (SE,p value) Tremor β (SE, p value)
Macroscopic Infarcts 0.359 (0.144, 0.013) 0.552(0.210, 0.009) 0.853(0.256,< 0.001) 0.420(0.185, 0.223) −0.212 (0.227, 0.351)
Microscopic Infarcts 0.149 (0.146, 0.308) 0.424(0.213, 0.047) 0.031(0.251, 0.902) −0.007(0.190, 0.972 −0.196(0.230, 0.293)
Arteriolosclerosis 0.055 (0.038, 0.150) 0.191(0.056, <0.001) 0.0.081(0.0.064, 0.052) 0.014(0.493, 0.774) −0.003(0.060, 0.964)
*

Based on regression model which included terms for age, sex, education and post-mortem evidence of Parkinson's disease.

Based on logistic regression model of presence or absence of Parkinsonian sign which included terms for age, sex, education and postmortem evidence of Parkinson's disease.

Based on Tobit model which included terms for age, sex, education and post-mortem evidence of Parkinson's disease.